CME ReviewMicrobiological aspects of bacterial lower respiratory tract illness in children: atypical pathogens
Introduction
The so-called ‘atypical’ pathogens were named for a distinct presentation of clinical disease in adults. In adults, these pathogens are commonly associated with non-respiratory symptoms and bilateral lung disease compared with the classical presentation of pneumococcal lobar pneumonia. This contrasts with the presentation in children which is frequently indistinguishable from that caused by ‘typical’ bacteria and by viruses, as each can cause isolated lobar consolidation and similar systemic responses. This makes identification of the causative organism of lower respiratory tract infection (LRTI) in children even more important and emphasizes the need for appropriate microbiological investigations.
The microbiological diagnosis of respiratory infection with atypical organisms in children is challenging. First, all of the problems applying to typical bacteria remain relevant, including the difficulty of obtaining an appropriate sample. Second, routine culture of these organisms is rarely a viable option. Third, the investigations for each of these pathogens often have limited sensitivity and specificity.
Despite these challenges, the appropriate use of clinical and laboratory information can shed light on the microbiological diagnosis of LRTI in many children. This review examines the current status of diagnostic techniques for Mycoplasma pneumoniae, Chlamydophila pneumoniae, Chlamydophila psittaci, Bordatella pertussis and Legionella species.
Section snippets
Mycoplasma pneumoniae
M. pneumoniae is the smallest known free-living organism. It is implicated in a wide spectrum of clinical disease involving multiple body systems. The most common presentation is with respiratory illness. Although other species of mycoplasma are described, the term mycoplasma here refers only to M. pneumoniae. Although there is no conclusive evidence that specific antibiotic treatment of mycoplasma respiratory infection affects the outcome of disease, it is common to treat symptomatic infection
Chlamydia and Chlamydophila
Chlamydia and the newly differentiated Chlamydophila are obligate intracellular organisms. Three species are prominent human pathogens. Chlamydophila pneumoniae and Chlamydophila psittaci most commonly cause respiratory disease. In the developed world Chlamydia trachomatis is most commonly a urogenital tract pathogen, which also causes neonatal pneumonia and conjunctivitis. In the developing world it is the cause of trachoma.
Immunity after primary infection with Chlamydia species is generally
Chlamydophila pneumoniae
C. pneumoniae is a primary human pathogen without any known animal reservoir. It causes LRTI but is also documented as frequently causing mild or asymptomatic infection. It causes invasive disease by entering cells, reproducing within cytoplasmic inclusions and being released with or without destruction of the host cell. Treatment for diagnosed infection is usually with macrolides or tetracyclines (in children over 8 years);9 however, there is no good evidence that this treatment is superior to
Chlamydophila psittaci
C. psittaci is the cause of psittacosis in humans. The natural reservoir for C. psittaci is birds, in which it can be symptomatic or asymptomatic. The bacterium is likely spread by the respiratory route. Humans are generally infected by direct contact with birds or their excreta or indirect contact, such as aerosolization of dead birds with a lawnmower.14 Person-to-person transmission is rare but can probably occur as psittacosis has been documented in healthcare workers exposed to patients
Legionella
Legionella species are a cause of both pulmonary and extrapulmonary infection. The most common manifestation is acute pneumonia, which may be either community- or hospital-acquired. The genus and the pulmonary infection, Legionnaires’ disease, were named after an outbreak that involved delegates at an American Legion convention in Philadelphia in 1976.16 Infection with Legionella species may produce significant morbidity and mortality if not recognized and treated promptly.
Legionella are small
Pertussis
Pertussis (whooping cough) is caused by the Gram negative pleomorphic bacterium Bordetella pertussis. Occasionally, similar disease can be caused by B. parapertussis. Although pertussis is part of the routine vaccine schedule in most developed countries, the organism remains a significant cause of disease.
Conclusion
In children, atypical pathogens often cause LRTI indistinguishable from that caused by other organisms. This makes specific microbiological investigation very important in this group. A very large range of novel investigations is available, and the clinician requires an understanding of the relative strengths and weaknesses of these tests for the identification of each pathogen when investigating LRTI. This review provides recommendations to help navigate the quagmire of available tests and to
Educational aims
- •
To discuss the characteristics of available tests for atypical lower respiratory tract pathogens as they apply to children.
- •
To provide evidence-based recommendations for the use of investigations for atypical pathogens in individual children with pneumonia.
Key points
- •
Diagnosis of atypical pathogens is challenging in children.
- •
Serological assays rarely provide diagnostic certainty in acute illness.
- •
Culture is not generally feasible for atypical pathogens.
- •
Nucleic acid amplification tests are likely to be the most useful tests for atypical pathogens.
CME Section
This article has been accredited for CME learning by the European Board for Accreditation in Pneumology (EBAP). You can receive 1 CME credit by successfully answering these questions online.
- (A)
Visit the journal CME site at http://www.prrjournal.com/.
- (B)
Complete the answers online, and receive your final score upon completion of the test.
- (C)
Should you successfully complete the test, you may download your accreditation certificate (subject to an administrative charge).
References (30)
- et al.
Evaluation of eight commercial tests for Mycoplasma pneumoniae antibodies in the absence of acute infection
Clin Microbiol Infect
(2006) - et al.
Prevalence of asymptomatic infection with Chlamydia pneumoniae in subjectively healthy adults
Chest
(2001) - et al.
The frequency of Legionella infection prospectively determined in children hospitalized with pneumonia
J Pediatr
(1981) - et al.
Problem pathogens: paediatric legionellosis – implications for improved diagnosis
Lancet Infect Dis
(2006) Pertussis in infants, children, and adolescents: diagnosis, treatment, and prevention
Semin Pediatr Infect Dis
(2006)- et al.
Recent developments in pertussis
Lancet
(2006) - et al.
Mycoplasma pneumoniae and its role as a human pathogen
Clin Microbiol Rev
(2004) - et al.
Mycoplasma pneumoniae infections in Australian children
J Paediatr Child Health
(2005) - et al.
Mycoplasma pneumoniae pneumonia: CT features in 16 patients
Eur Radiol
(2006) - et al.
No evidence of Mycoplasma pneumoniae in acute myringitis
Pediatr Infect Dis J
(2004)
Sample type is crucial to the diagnosis of Mycoplasma pneumoniae pneumonia by PCR
J Med Microbiol
Portacion faringea de Mycoplasma pneumoniae en ninos chilenos
Revista Chilena de Infectologia
Results of molecular detection of Mycoplasma pneumoniae among patients with acute respiratory infection and in their household contacts reveals children as human reservoirs
J Infect Dis
Chlamydial infections
Pneumonia due to Chlamydia pneumoniae in children: epidemiology, diagnosis, and treatment
Pediatr Pulmonol
Cited by (33)
Evaluation of the usefulness of culture of induced sputum and the optimal timing for the collection of a good-quality sputum sample to identify causative pathogen of community-acquired pneumonia in young children: A prospective observational study
2023, Journal of Microbiology, Immunology and InfectionInfections and Diseases of the Lungs, Pleura, and Mediastinum
2012, Pediatric Surgery, 2-Volume Set: Expert Consult - Online and PrintInfections and Diseases of the Lungs, Pleura, and Mediastinum
2012, Pediatric SurgeryPneumonia caused by Mycoplasma pneumoniae and Chlamydophila pneumoniae in children - Comparative analysis of clinical picture
2011, Advances in Medical SciencesCitation Excerpt :In primary infection IgG antibodies appear much later than IgM antibodies. Secondary and chronic infection often runs without or with low titer of IgM antibodies, while there are frequently high titers of IgA and IgG antibodies [1–3,5,8,27]. In the performed study, positive titer of specific IgA antibodies against Mycoplasma pneumoniae and/or Chlamydophila pneumoniae was observed in 3.5% and 4.9% of the children (respectively), thus suggesting chronic infection.
Endotracheal tube biofilm inoculation of oral flora and subsequent colonization of opportunistic pathogens
2010, International Journal of Medical MicrobiologyCharacterisation of acid-base abnormalities in pigs experimentally infected with Chlamydia suis
2010, Veterinary Journal